[Munich, ] GÖRG Partnerschaft von Rechtsanwälten mbB advised bm-t beteiligungsmanagement thüringen gmbh on its investment in c-LEcta GmbH under the leadership of Dr. Christian Schröder. c-LEcta, a worldwide leading biotechnology company with a focus on enzyme engineering and applications in regulated markets such as the food and pharmaceutical industries, has completed a financing round with the investor bm|t. Capricorn Venture Partners, an independent, internationally oriented investment company, based in Leuven, Belgium, also invested. The capital increase provides the company with growth capital and valuable access to an international network.
bm|t invests in high-growth companies has extensive expertise in various technology areas It is the largest growth investor in Thuringia. bm|t invested via the MFT Mittelstands-Fonds Thüringen GmbH & Co. KG. The new capital will be used in particular to finance the approval, market launch and scaling of products from the project pipeline on a commercial scale, the further development of the pipeline and the expansion of international sales.
Advisors bm-t beteiligungsmanagement thüringen gmbh
Dr. Christian Schröder, Counsel (lead), Corporate/ M&A
Dr. Christian Glauer, Associated Partner, Corporate/ M&A,
Tobias Reichenberger, Associate, Corporate/ M&A,
Dr. Melanie Ries, Associate, IP (all Munich)
About bm-t beteiligungsmanagement thüringen gmbh
bm-t beteiligungsmanagement thüringen gmbh was founded in 2003 as a universal investment company for Thuringia and is a subsidiary of Thuringia development bank. Their aim is to strengthen Thuringia's economy through targeted investments in innovative and growth-oriented companies.
About c-LEcta GmbH
c-LEcta GmbH was established as leading provider in the realisation of high-quality biotechnological products, as well in own developments as in close cooperation with the industry and is based in Leipzig.
c-LEcta currently employs around 60 people.
